Found 1 entry matching your search criteria.
||Bell, I. H., Lim, M. H., Rossell, S. L., & Thomas, N. (2017). Ecological momentary assessment and intervention in the treatment of psychotic disorders: A systematic review. Psychiatric Services, 68(11), 1172-1181.
||Computer applications, daily living, disability management, electronics, feasibility studies, health care, health promotion, intervention, literature reviews, measurements, mental health, outcomes, psychiatric telecommunications, telephones
||This systematic review synthesized research exploring the feasibility, acceptability, and clinical outcomes of ecological momentary assessment (EMA) and ecological momentary intervention (EMI) in the treatment of psychotic disorders. EMA and EMI are technologies used to track fluctuations in experiences and prompt behavioral responses within the context of a person’s daily life. Most commonly delivered via smartphone, EMA and EMI have potential to provide simple, cost-effective, and user-led treatment for psychotic disorders. Relevant studies published between 1980 and July 7, 2016, were identified by searching PubMed, PsycINFO, PsycARTICLES, and the Cochrane Central Register of Controlled Trials with combinations of search terms related to mobile devices, EMA and EMI, and psychotic disorders. Of 1,623 studies identified, nine met inclusion criteria for the review. These studies found satisfactory feasibility and acceptability and preliminary evidence of improved clinical outcomes. The interventions, which had a broad array of features, targeted remote monitoring of illness and symptoms, and they also targeted illness self-management by using momentary reminders or instructions for behaviors, including medication adherence, management of symptoms and psychosocial impairments, daily living skills, and goal achievement. The findings provide preliminary support for the clinical utility of EMA and EMI in the treatment of psychotic disorders. Future research should explore further applications of these technologies with larger sample sizes and controlled designs.
|Full-Text Availability Options:||https://www.ncbi.nlm.nih.gov/pubmed/28669284|